4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: A Rare and Lethal Entity.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ewing sarcoma/primitive neuroectodermal tumor represents a spectrum of undifferentiated tumors with similar biology that together represent the second most common sarcoma in the pediatric-young adult age range. Very rarely, this tumor presents as a primary neoplasm of the kidney. The clinical presentation of this tumor is not specific, and other renal tumors may present with a similar histologic appearance. Establishing the correct diagnosis is critical because renal Ewing sarcoma/primitive neuroectodermal tumor carries a strikingly dismal prognosis and thus dictates a specific treatment strategy. A low threshold for the use of ancillary molecular tests is recommended, particularly in diagnostically problematic cases. Important considerations with regards to morphology, immunohistochemistry, and molecular alterations will be reviewed here and should be taken into account before rendering this rare and lethal diagnosis.

          Related collections

          Author and article information

          Journal
          Arch. Pathol. Lab. Med.
          Archives of pathology & laboratory medicine
          Archives of Pathology and Laboratory Medicine
          1543-2165
          0003-9985
          Mar 2016
          : 140
          : 3
          Affiliations
          [1 ] From the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.
          Article
          10.5858/arpa.2014-0367-RS
          26927724
          066d2cd5-ac21-48cd-a603-ef8c497fab03
          History

          Comments

          Comment on this article